Microneedle delivery: Clinical studies and emerging medical applications

Therapeutic Delivery

Volumn 3, Issue 3, 2012, Pages 357-371

  Pettis, Ronald J ^a   Harvey, Alfred J ^a  

^a BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; INFLUENZA VACCINE; INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO; LIDOCAINE; LOCAL ANESTHETIC AGENT; NALTREXONE; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; SOLUVIA; UNCLASSIFIED DRUG;

ALCOHOLISM; ANTIBODY TITER; AXILLARY LYMPH NODE; CLINICAL EFFECTIVENESS; CONTROLLED DRUG RELEASE; DEVICE SAFETY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; EQUIPMENT DESIGN; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA VACCINATION; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; LOW DRUG DOSE; MICROENCAPSULATION; NEEDLE; NONHUMAN; OPIATE ADDICTION; OSTEOPOROSIS; PAIN; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; SEROCONVERSION; SKIN CARE; SKIN PENETRATION; SKIN PERMEABILITY; SOLID STATE; STRATUM CORNEUM; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSDERMAL PATCH; TUBERCULIN TEST; VALIDATION PROCESS;

EID: 84858135604     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.13     Document Type: Review

References (47)

1. Sachdeva V, Banga AK. Microneedles and their applications. Recent Pat. Drug Deliv. Formul. 5, 95-132 (2011).
2. Birchall JC. Microneedle array technology: the time is right but is the science ready? Expert Rev. Med. Devices 3, 1-4 (2006).
3. Donnelly RF, Raj Singh TR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery and safety. Drug Deliv. 17, 187-207 (2010).
4. Kaushik F, Hord AH, Denson DD et al. Lack of pain associated with microfabricated microneedles. Anesth. Analg. 92, 502-504 (2001). (Pubitemid 32127644)
5. Donnely RF, Raj TR, Tunney MM et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm. Res. 26(11), 2513-2522 (2009).
6. Birchall JC, Clemo R, Anstey A. Microneedles in clinical practice-an exploratory study into the opinions of healthcare professionals and the public. Pharm. Res. 28, 95-106 (2011).
7. Sivamani RK, Liepmann D, Maibach HI. Microneedles and transdermal applications. Expert Opin. Drug Deliv. 4, 19-25 (2007). (Pubitemid 46117483)
8. Sivamani RK, Stoeber B, Wu GC et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res. Technol. 11, 152-156 (2005). (Pubitemid 40542856)
9. Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA et al. Microneedles: a valuable physical enhancer to increase transdermal drug delivery. J. Clin. Pharmacol. 51, 964-977 (2011).
10. Gupta J, Park SS, Bondy B et al. Infusion pressure and pain during microneedle injection into the skin of human subjects. Biomaterials 32, 6823-6831 (2011).
11. Laurent PE, Bonnet S, Alchas P et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25, 8833-8842 (2007). (Pubitemid 350192056)
12. Mikszta JA, Alarcon JB, Brittingham JM et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat. Med. 8, 415-419 (2002). (Pubitemid 34407039)
13. Bal SM, Caussin J, Pavel S et al. In vivo assessment of safety of microneedle arrays in human skin. Eur. J. Pharm. Sci. 35, 193-202 (2008).
14. Haq MI, Smith E, John DN et al. Clinical administration of microneedles: skin puncture, pain and sensation. Bio. Microdevices 11, 35-47 (2009).
15. Gupta J, Gill HS, Andrews SN et al. Kinetics of skin resealing after insertion of microneedles in human subjects. J. Control. Release 154(2), 148-155 (2011).
16. Miyano T, Tobunaga Y, Kanno T et al. Sugar micro needles as transdermic drug delivery system. Biomed. Microdevices 7, 185-188 (2005). (Pubitemid 41236286)
17. Gill HS, Denson DD, Burris BA et al. Effect of microneedle design on pain in human subjects. Clin. J. Pain 24, 585-594 (2008).
18. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M et al. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27, 454-459 (2009).
19. Parodi V, de Florentiis D, Martini M et al. Inactivated influenza vaccine: recent progress and implications for the elderly. Drugs Aging 28, 93-106 (2011).
20. Vankerckhoven V, Van Damme P. Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines. Expert Opin. Drug Deliv. 7, 1109-1125 (2010).
21. Ansaldi F, Durando P, Icardi G. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin. Biol. Ther. 11, 415-427 (2011).
22. Duggan ST, Plosker GL. Intanza 15 microg intradermal seasonal influenza vaccine in older adults (aged ≥60 years). Biodrugs 24, 407-409 (2010).
23. Arnou R, Icardi G, De Decker M et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter Phase III study. Vaccine 27, 7304-7312 (2009).
24. Arnou R, Eavis P, De Juanes Pardo JR et al. Immunogenicity, large-scale safety, and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years. Hum. Vaccines 6, 346-354 (2010).
25. Leroux-Roels I, Vets E, Freese R et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine. 26(51), 6614-6619 (2008).
26. Holland D, Booy R, De LF et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J. Infec. Dis. 198, 650-658 (2008).
27. Beran J, Ambrozaitis A, Laiskonis A et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med. 7, 13 (2009).
28. Morelon E, Noble CP, Daoud S et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 28, 6885-6890 (2010).
29. Reygrobellet C, Viala-Danten M, Meunier J et al. Perception and acceptance of intradermal influenza vaccination. Hum. Vaccines 6, 336-345 (2010).
30. Prausnitz MR. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56, 581-587 (2004). (Pubitemid 38326934)
31. Heinemann L, Hompesch M, Kapitza C et al. Intra-dermal insulin lispro application with a new microneedle delivery system led to a substantially more rapid insulin absorption than subcutaneous insulin injection. Diabet. Med. 23(Suppl. 4), 329 (2006).
32. Pettis RJ, Ginsberg B, Hirsch L et al. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabet. Technol. Ther. 13, 435-442 (2011).
33. Gupta J, Felner EI, Prausnitz MR. Minimally invasive insulin delivery in subjects with Type 1 diabetes using hollow microneedles. Diabet. Technol. Ther. 11, 329-337 (2009).
34. Gupta J, Felner EI, Prausnitz MR. Rapid pharmacokinetics of intradermal insulin administered using microneedles in Type 1 diabetes subjects. Diabet. Technol. Ther. 13, 451-456 (2011).
35. Pettis RJ, Hirsch L, Kapitza C et al. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with Type 1 diabetes. Diabet. Technol. Ther. 13, 443-450 (2011).
36. Ameri M, Daddona PE, Maa YF. Demonstrated solid-state stability of parathyroid hormone PTH(13-4) coated on a novel transdermal microprojection delivery system. Pharm. Res. 26, 2454-2463 (2009).
37. Daddona PE, Matriano JA, Mandema M. Parathyroid hormone (I-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm. Res. 28, 159-165 (2011).
38. Cosman F, Lane NE, Bolognese MA et al. Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J. Clin. Endocrinol. Metab. 95, 151-158 (2010).
39. Gupta J, Denson DD, Felner EI et al. Rapid local anesthesia in humans using minimally invasive microneedles. Clin. J. Pain 28(2), 129-135 (2012).
40. Li X, Zhao R, Qin Z et al. Microneedle pretreatment improves efficacy of cutaneous topical analgesia. Am. J. Emerg. Med. 28, 130-134 (2010).
41. Sevick-Muraca EM, Sharma R, Rasmussen JC et al. Imaging of lymph flow in breast cancer patients after microdose administration of near-infrared fluorophore: feasibility study. Radiology 246, 734-741 (2008).
42. Kim SE, Lee JH, Bu Kwon H et al. Greater collagen deposition with the microneedle therapy system than with intense pulsed light. Dermatol. Surg. 37, 336-341 (2011).
43. Orentreich DS, Orentreich N. Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol. Surg. 21, 543-549 (1995).
44. Fabbrocini G, Fardella N, Monfrecola A et al. Acne scarring treatment using skin needling. Clin. Exp. Dermatol. 34, 874-879 (2009).
45. Wermeling DP, Banks SL, Hudson DA et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc. Natl Acad. Sci. USA 105, 2058-2063 (2008). (Pubitemid 351439464)
46. Jiang J, Moore JS, Edelhauser HF et al. Intrascleral drug delivery to the eye using hollow microneedles. Pharm. Res. 26(2), 395-403 (2009).
47. Coulman SA, Birchall JC, Alex A et al. In vivo, in situ imaging of microneedle insertion into the skin of human voluneteers using optical coherence tomography. Pharm Res. 28, 66-81 (2011).